Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × moxonidine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 1

Interventions

Cyclophosphamide 2655 Cisplatin 2626 Carboplatin 2427 Radiotherapy 2244 Paclitaxel 2229 Gemcitabine 2106 pembrolizumab 1945 Docetaxel 1847 Bevacizumab 1757 Fluorouracil 1526 Capecitabine 1493 Oxaliplatin 1416 Dexamethasone 1320 Nivolumab 1245 Doxorubicin 1241 Rituximab 1221 Etoposide 1123 Magnetic Resonance Spectroscopy 1049 Irinotecan 1027 Leucovorin 1010 Cytarabine 958 Drug Therapy 882 fludarabine 879 Pemetrexed 878 Vincristine 788 Lenalidomide 773 Prednisone 772 Cetuximab 762 Filgrastim 759 Specimen Handling 754

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01504321 2018-11-02

Polycystic Ovary Syndrome - Improving Outcomes

Baker Heart and Diabetes Institute

Phase 4 Completed

Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡